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Effect of 3-mercaptopyruvate Sulfurtransferase Deﬁciency 
on the Development of Multiorgan Failure, Inﬂammation, 
and Wound Healing in Mice Subjected to Burn Injury
Akbar Ahmad, PhD,* Nadiya Druzhyna, PhD,* and Csaba Szabo, MD, PhD, FPBS*,†,‡  
The gaseous transmitter hydrogen sulﬁde (H2S) has been implicated in various forms of critical illness. Here, we 
have compared the outcome of scald burn injury in wild-type mice and in mice deﬁcient in 3-mercaptopyruvate 
sulfurtransferase (3-MST), a mammalian H2S-generating enzyme. Outcome variables included indices of organ 
injury, clinical chemistry parameters, and plasma levels of inﬂammatory mediators. Plasma levels of H2S signiﬁcantly 
increased in response to burn in wild-type mice, but remained unchanged in 3-MST-/- mice. The capacity of tissue 
homogenates to produce H2S from 3-mercaptopyruvate was unaffected by burn injury. In 3-MST
-/- mice, compared 
to wild-type controls, there was a signiﬁcant enhancement in the accumulation of polymorphonuclear cells (as 
assessed by the quantiﬁcation of myeloperoxidase) in the liver (but not heart, lung, or skin) at 7 days postburn. 
Oxidative tissue damage (as assessed by malon dialdehyde content) was comparable between wild-type and 3-MST-
deﬁcient mice in all tissues studied. 3-MST-/- and wild-type mice exhibited comparable burn-induced elevations 
in circulating plasma levels of hepatic injury; however, 3-MST-/- mice exhibited a higher degree of renal injury (as 
reﬂected by elevated blood urea nitrogen levels) at 7 days postburn. Inﬂammatory mediators (eg, TNF-α, IL-1β, 
IL-2, IL-6, IL-10, and IL-12) increased in burn injury, but without signiﬁcant differences between the 3-MST-
/- and wild-type groups. The healing of the burn wound was also unaffected by 3-MST deﬁciency. In conclusion, 
the absence of the H2S-producing enzyme 3-MST slightly exacerbates the development of multiorgan dysfunction 
but does not affect inﬂammatory mediator production or wound healing in a murine model of burn injury.
Hydrogen sulﬁde (H2S) is an endogenous gasotransmitter, 
which regulates multiple physiological and pathophysiologi-
cal functions in the vascular, immune, and nervous system.1–6 
H2S biogenesis in mammals is catalyzed by three enzymes: 
cystathionine-gamma-lyase (CSE), cystathionine-beta-
synthase (CBS), and 3-mercaptopyruvate sulfurtransferase 
(3-MST).1–6
The regulatory roles of H2S are emerging in various forms 
of critical illness7–22 including burn injury.23–36 In some forms 
of critical illness (eg, endotoxic shock, septic shock, as well 
as in burn injury), increased circulating H2S levels have been 
reported, and in many—but not all—published studies, phar-
macological inhibition of H2S production, or genetic defi-
ciency of H2S-producing enzymes exerted beneficial effects. 
In other forms of critical illness (eg, ischemia-reperfusion, or 
hemorrhagic shock), H2S degradation appears to be increased, 
resulting in local or systemic H2S deficiency; accordingly, in 
these conditions H2S donors (ie, pharmacological supplemen-
tation of H2S) was found to be therapeutically advantageous. 
However—and in line with the characteristic bell-shaped con-
centration-response of H2S, where low vs high concentrations 
of this mediator can exert opposing biological effects in mod-
ulating cell injury and inflammatory mediator production—in 
several preclinical models of critical illness, including murine 
burn models—both H2S donors and H2S synthesis inhibitors 
have been shown to exert beneficial effects.23–26
It was recently demonstrated that deficiency in CSE exerts 
beneficial effects in a mouse model of burn injury.36 However, 
CSE is only one of the enzymes that contributes to the bio-
synthesis of H2S; two other enzymes, CBS and 3-MST also 
play important roles. So far, the pathophysiological role of 
3-MST has been relatively less studied, in part because, until 
recently, specific experimental tools (eg, mice deficient in 
3-MST or pharmacological inhibitors of 3-MST) have not 
been available.1 The goal of the current study, therefore, was 
to elucidate the potential role of 3-MST on the development 
of multiorgan injury and inflammatory responses in a mouse 
model of burn injury.
METHODS
Materials
Unless indicated otherwise, all other all chemicals were 
obtained from Sigma-Aldrich (St. Louis, MO).
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Animals and Experimental Design
Male wild-type and 3-MST-/- mice37 (a kind gift of Dr. Noriyuki 
Nagahara, Isotope Research Center, Nippon Medical School, 
1-1-5 Sendagi, Bunkyo-ku, Tokyo 113–8602, Japan) (10–12 
weeks of age) were housed at 24 to 26°C on a 12:12 light:dark 
cycle and subjected to burn injury as described.38,39 Briefly, 
mice were anesthetized by isoflurane (3–5% inhalation). After 
an intraperitoneal (i.p.) injection of buprenorphine (0.1 mg/
kg), ~40% of the dorsum was shaved and approximately 1 ml 
Ringer’s lactate solution was injected under the skin along 
the spinal column. Subsequently, the dorsa were subjected to 
~95°C water for 10 seconds. This produces a full thickness 
scald wound (~30% of the total BSA). The animals received 
2 ml Ringer’s lactate for resuscitation. In order to minimize 
animal suffering, pain, or distress, animals were scored twice 
daily and evaluated based on an IACUC-approved Rodent 
Intervention Score Sheet. Buprenorphine was administered 
when needed indicated to reduce pain and distress.
N = 30 wild-type and N = 30 3-MST-/- animals were used 
in the current study. Groups of animals (n  =  10 wild-type 
and n = 10 3-MST-/-) were sacrificed at 24 hours, 7 days, or 
21  days under anesthesia and blood, heart, lung, liver, and 
kidney tissues and skin tissue around the burn were harvested 
for analysis. Additional 10 wild-type animals were used as 
wild-type sham and additional 10 3-MST-/- animals were used 
as 3-MST-/- sham animals (all killed at 24 hours).
The current investigation conforms to the Guide for 
the Care and Use of Laboratory Animals published by the 
National Institutes of Health (Eight Edition, 2011) and was 
performed in accordance with the IACUC, University of 
Texas Medical Branch, Galveston, TX, USA.
Measurement of Plasma H2S Levels
Plasma H2S levels at 24 hours postburn were measured using 
the fluorescent dye 7-azido-4-methylcoumarin (AzMC) 
as described.29 Plasma H2S concentrations were calculated 
against a Na2S standards reacted with AzMC and were 
expressed as µM.
Measurement of Tissue H2S Production
H2S production in tissue homogenates was measured using 
AzMC as described.33 Briefly, tissues were homogenized and 
AzMc (10 μM), and either the CBS substrates L-cysteine and 
homocysteine (each at 2.5  mM final concentration) or the 
3-MST substrate 3-mercaptopyruvate (2 mM final concentra-
tion) was added to the homogenate and H2S fluorescence was 
measured at 3 hours. The L-cysteine/homocysteine-induced 
H2S production was used to estimate CBS activity and the 
3-mercaptopyruvate-induced H2S production was used to 
estimate 3-MST activity. H2S production was calculated 
against Na2S standards reacted with AzMC and expressed as 
femtomoles of H2S produced/mg total tissue protein/min.
Myeloperoxidase Assay
Myeloperoxidase (MPO) activity, an indicator of tissue poly-
morphonuclear leukocyte accumulation, was measured in 
heart, lung, liver, and kidney homogenates using a commer-
cially available myeloperoxidase fluorometric detection kit 
(Enzo Life Sciences, , Farmingdale, NY) as described.39
Malondialdehyde Assay
Tissue malondialdehyde (MDA) levels, an index of cellular 
injury/oxidative stress, were measured in heart, lung, liver, 
and kidney homogenates using a fluorimetric MDA-specific 
lipid peroxidation assay kit (Enzo Life Sciences) as described.39
Measurement of Biochemical Parameters of Organ 
Dysfunction
Blood samples were collected via cardiac puncture and were 
analyzed by using a Vetscan analyzer as described39 for various 
biochemical parameters within 1 hour of collection.
Quantification of Plasma Cytokine Levels
Blood from all groups were collected into heparinized blood 
collection tubes and processed within 30 minutes of collection. 
Blood was centrifuged at 4°C for 10 minutes at 1000g. Plasma 
collected and stored at −80°C until analysis, using the Luminex 
system and Invitrogen’s Mouse Cytokine Magnetic 10-plex 
Panel kit, as described.39 Simultaneous quantification of the fol-
lowing analytes was conducted: tumor-necrosis factor α (TNF-
α), interleukin (IL)-1β , IL-2, IL-4, IL-6, IL-10, IL-12 p70, 
interferon γ-induced protein 10 kDa (IP 10), chemokine (C-X-C 
motif) ligand 1/keratinocyte chemoattractant (KC), monocyte 
chemoattractant protein 1 (MCP-1), regulated on activation, 
normal T cell expressed and secreted/chemokine (C-C motif) 
ligand 5 (RANTES), vascular endothelial growth factor (VEGF), 
granulocyte-colony stimulating factor (G-CSF), and granulo-
cyte-macrophage colony stimulating factor (GM-CSF).
Quantification of Wound Size
Wound areas at 24 hours after burn (to obtain a baseline value) 
and at 21 days were quantified as previously described,39 using 
a transparent sheet and the NIS Elements Imaging Software 
(Nikon).
Statistical Analysis
The study was conducted in such a way that the person taking 
the measurements was blinded to the identity of the treatment 
groups. Numerical values in the text and figures are expressed 
as mean ± SEM for n observations. Student’s t-test, one-way 
and two-way analysis of variance with Tukey’s post hoc test 
were used to detect difference between groups using the Graph 
Pad software. P < .05 was considered statistically significant.
RESULTS
H2S Production and Activity of H2S-producing 
Enzymes
Burn injury in wild-type mice resulted in an increase in circu-
lating H2S levels, as assessed by the fluorescent dye AzMC. 
However, no increase in circulating H2S was seen in the 
3-MST-/- mice (Figure 1), suggesting that 3-MST contributes 
to the burn-induced elevation in circulating H2S levels.
Next, the H2S-producing capacity of liver and kidney 
homogenates was measured. H2S production in response to 
cysteine/homocysteine was considered as an estimator of CBS 
activity; H2S production in response to 3-mercaptopyruvate was 
used as an estimator of 3-MST activity (Figure 2). In the liver, 
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maximal H2S production in response cysteine/homocysteine 
(ie, CBS-dependent H2S production) was higher than maximal 
H2S production in response to 3-mercaptopyruvate (ie, 3-MST-
dependent H2S production), while in the kidney, 3-MST activity 
was approximately twice as high as CBS activity (Figure 2). In 
3-MST-/- liver homogenates, as expected, 3-mercaptopyruvate-
induced H2S production was completely absent. However, 
surprisingly, in 3-MST-/- tissues, the cysteine/homocysteine-
dependent H2S production was lower than the corresponding 
levels in wild-type tissues, perhaps indicating an activating inter-
action between the 3-MST and the CBS system in these tissues.
Burn failed to affect either 3-mercaptopyruvate-catalyzed 
H2S production in liver and kidney homogenates; however, 
cysteine+homocysteine-dependent H2S production appeared 
to increase over baseline at 7 days postburn (Figure 2).
Effect of CSE Deficiency on Multiorgan Injury and 
Systemic Inflammatory Response in Burns
Burn induced marked increases in lung, liver, heart, and 
kidney MPO and MDA levels, indicating, respectively, the in-
filtration of these tissues with polymorphonuclear cells, and 
increased oxidative burden of the tissues (Figures 3 and 4). 
The patterns and magnitudes of these burn-induced increases 
were, generally, comparable in wild-type mice and 3-MST-/- 
mice, with the exception of the liver, where MPO levels 7 days 
postburn were higher in the 3-MST-/- mice than in the wild-
type control mice (Figure 3), possibly indicating a slight pro-
tective role of endogenously produced, 3-MST-derived H2S.
Burn injury also induced marked changes in the clinical 
chemistry parameters and organ injury markers of the animals. 
There was an increase in the plasma levels of the hepatic/bone 
injury marker alkaline phosphatase, the hepatic injury marker 
alanine aminotransferase, the pancreatic injury marker amy-
lase, and the renal dysfunction markers creatinine and blood 
urea nitrogen (Figures 5 and 6). Many of these parameters 
peaked at 24 hours, but alkaline phosphatase levels remained 
increased by 21 days postburn. Plasma blood urea nitrogen 
levels tended to be higher in 3-MST-/- mice even under base-
line conditions, and they became significantly more elevated 
in 3-MST-/- mice than in wild-type mice 7  days postburn, 
perhaps indicative of a slight protective role of endogenous, 
3-MST-derived H2S against renal dysfunction (Figure 5).
Consistent with the systemic inflammatory response syn-
drome associated with burns, burn markedly increased the 
plasma levels of multiple chemokines, cytokines, and colony-
stimulating and angiogenic hormones; however, plasma levels 
of these mediators were unaffected by the absence of 3-MST 
(Figures 7 and 8).
There were no differences in plasma troponin-I levels be-
tween wild-type and 3-MST-deficient mice postburn, nor 
were any statistically significant differences in the rate of 
wound healing between the wild-type and the 3-MST-/- ani-
mals (Figure 9).
DISCUSSION
It been previously proposed that the role of H2S in burn may 
be time-dependent, with pro-inflammatory actions dominating 
in the early stages of the disease, and anti-inflammatory and 
wound-healing-modulating effects dominating in later stages.30 
However, the relative role of the various H2S-producing 
enzymes in burns remains incompletely understood. Based on 
the beneficial effect of the CBS/CSE inhibitor aminooxyacetic 
acid,25 it was previously hypothesized that CBS-derived H2S 
plays a pathophysiological, deleterious role in burns. Moreover, 
based on the protection seen in CSE-deficient mice,36 it was 
previously concluded that CSE-derived H2S also plays a path-
ogenetic role in this model. Other studies have measured 
H2S-producing enzyme expression levels and circulating H2S 
concentrations, and demonstrated that in rodent models of 
burn, CSE mRNA expression is upregulated26 and both in ro-
dent models of burn as well as in patients with burn, circulating 
H2S levels are increased.
26,29 Taken together, these experiments 
indicate that CSE- and CBS-derived H2S both play pathoge-
netic (deleterious) roles in burns, by promoting inflamma-
tory mediator production and exacerbating end-organ injury. 
However, the role of 3-MST in the pathogenesis of burn injury 
has not yet been elucidated, most likely because, until recently, 
neither mice deficient in 3-MST, nor sufficiently potent or se-
lective pharmacological inhibitors of 3-MST were available.
The measurement of circulating H2S levels in the current 
study confirms and extends earlier studies25,29,36 showing that 
burn induces an increase in circulating H2S levels and suggests 
that 3-MST is involved in this increase, because burn failed to 
increase circulating H2S levels in 3-MST
-/- mice (Figure 1). 
The tissue source of the increased 3-MST-derived H2S pro-
duction was not identified in the current study, as the liver 
and kidney tissues studied by us did not exhibit any increases 
in the activity of 3-MST, at least at the maximal (saturating) 
substrate (3-mercaptopyruvate) concentrations employed in 
this assay (Figure 2). These results do not, however, exclude 
the possibility that 3-MST (and/or other H2S-synthesizing 
enzymes) become upregulated in response to burn in other 
cells or tissues that were not examined by us.
One interesting observation is that in tissues from 3-MST-/- 
mice, the L-cysteine/homocysteine-induced H2S produc-
tion (which estimates CBS activity) was lower than the 
Figure 1. Effect of burn on plasma H2S levels in wild-type and 
3-MST-/- mice. Data show that H2S plasma levels in sham mice and 
in wild-type (WT) and 3-MST-/- mice subjected to 24 hours of burn. 
H2S plasma levels increased in wild-type animals after burn; however, 
in 3-MST-/- mice, sham and postburn plasma H2S levels are same. 
Data are shown as mean ± SEM of 10 animals for each group; *P < 
.05 shows signiﬁcant increase in H2S levels in response to burn, com-
pared to the sham group.
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Figure 3. Burn injury increases in lung, liver, skin, and kidney myeloperoxidase (MPO) levels. Lung (A), liver (B), skin (C), and kidney (D) MPO 
levels (expressed as milliunits [mU]/g tissue) are shown in wild-type (WT) mice and in 3-MST-/- mice subjected to sham injury or to burn injury 
(24 hours, 7 days, and 21 days). Burn signiﬁcantly increased MPO levels at 24 hours, 7 days, and 21 days (P < .05) compared to the values mea-
sured in sham animals. MPO levels in 3-MST-/- burn mice were signiﬁcantly increased as compared to wild-type burn mice in liver homogenates 
at 7 days. Data are shown as mean ± SEM of 10 animals for each group; *P < .05 shows signiﬁcant increase in MPO in response to burn mice, 
compared to the sham group; #P < .05 shows signiﬁcant increases in 3-MST-/- burn mice compared to wild-type burn mice.
Figure 2. Effect of burn on the enzymatic activity of cystathionine-beta-synthase (CBS) and 3-MST in wild-type and 3-MST-/- mice. Data show 
H2S production by liver homogenates in response to cysteine/homocysteine (an index of CBS activity) and in response to 3-mercatopyruvate (an 
index of 3-MST activity) in wild-type (WT) sham mice, in wild-type mice subjected to 24 hours and 7 days of burn, in 3-MST-/- sham mice and in 
3-MST-/- mice subjected to 24 hours and 7 days of burn. Burn signiﬁcantly increased CBS activity in liver (A) and kidney (C) samples from wild-
type and 3-MST-/- mice at 7 days. 3-MST activities were comparable in liver (B) and kidney (D) samples from wild-type mice subjected to burn. 
Data are shown as mean ± SEM of 10 animals for each group; *P < .05 shows signiﬁcant increase in CBS activity in response to burn, compared 
to the sham group.
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Figure 4. Burn injury increases in lung, liver, skin, and kidney malondialdehyde (MDA) levels. Lung (A), liver (B), skin (C), and kidney (D) MDA 
levels are shown in wild-type (WT) mice and in 3-MST-/- mice subjected to sham injury or to burn injury (24 hours, 7 days, and 21 days). Burn 
signiﬁcantly increased MDA levels at 24 hours, 7 days, and 21 days (P < .05) compared to the value measured in sham animals. Data are shown as 
mean ± SEM of 10 animals for each group; *P < .05 shows signiﬁcant increase in MDA in response to burn, compared to the sham group.
Figure 5. Burn injury increases selected parameters of organ injury. Various physiological and organ injury marker levels (albumin (A), alkaline 
phosphatase (B), alanine aminotransferase (C), amylase (D), total bilirubin (E), plasma blood urea nitrogen (F), plasma calcium (G) and plasma 
phosphate (H)) measured by Vetscan analysis, are shown in wild-type (WT) mice and in 3-MST-/- mice subjected to sham injury or to burn injury 
(24 hours, 7 days, and 21 days). Burn signiﬁcantly increased the indicated parameter at 24 hours, 7 days, and 21 days (P < .05) compared to the 
value measured in sham animals. The blood urea nitrogen level in 3-MST-/- burn mice was signiﬁcantly higher than the corresponding values in 
wild-type burn mice at 7 days. Data are shown as mean ± SEM of 10 animals; *P < .05 shows signiﬁcant changes in response to burn, compared 
to the sham group; #P < .05 shows a signiﬁcantly higher increase in 3-MST-/- burn mice compared to wild-type burn mice.
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corresponding H2S production in wild-type tissues. This is 
an unexpected finding, because the two enzymes have previ-
ously not been linked functionally. Although the substrate of 
3-MST (3-mercaptopyruvate) is produced from cysteine, and 
cysteine is also a substrate of CBS, this commonality will also 
not explain the reduced tissue CBS activity in the 3-MST-/- 
mice. The mechanism and the potential functional importance 
of these changes remain to be further explored.
Figure 7. Burn injury increases cytokine levels in plasma samples. Plasma cytokine levels, measured by Luminex analysis, are shown in wild-type 
(WT) mice and in 3-MST-/- mice subjected to sham injury or to burn injury (24 hours, 7 days, and 21 days). Burn markedly increased plasma TNF-
α (A), IL-β (B), IL-2 (C), IL-4 (D), IL-6 (E), IL-10 (F), IL-12(p70) (G), and IP-10 (H) levels in wild-type and 3-MST-/- mice at 24 hours, 7 days, 
and 21 days. Data are shown as mean ± SEM of 10 animals; *P < .05 shows signiﬁcant changes in response to burn, compared to the sham group.
Figure 6. Burn injury increases in selected parameters of organ injury. Various physiological and organ injury marker levels (plasma creatinine (A), 
plasma glucose (B), plasma sodium (C), plasma potassium (D), plasma total protein (E) and plasma globulin (F)) measured by Vetscan analysis, are 
shown in wild-type (WT) mice and in 3-MST-/- mice subjected to sham injury or to burn injury (24 hours, 7 days, and 21 days). Burn signiﬁcantly 
increased the indicated parameter at 24 hours, 7 days, and 21 days (P < .05) in wild-type and 3-MST-/- mice compared to the value measured in 
sham animals. Data are shown as mean ± SEM of 10 animals; *P < .05 shows signiﬁcant changes in response to burn, compared to the sham group.
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Based on prior studies focusing on CBS and CSE, our 
working hypothesis was that 3-MST deficiency will also exert 
protective effects in burns. However, unexpectedly, 3-MST 
deficiency did not provide any protective effects in burn in 
various tissues, nor did it affect circulating inflammatory 
mediator production. On a few selected parameters, at a few 
time points, we have even observed an exacerbation of the 
burn-induced pathophysiological changes in the 3-MST-/- 
mice, although we must keep in mind that these differences 
are relatively minor, and, overall, probably the correct con-
clusion should be that wild-type and 3-MST-deficient mice 
behave, in almost all respects, in the same manner when sub-
jected to burn injury.
It should be noted that a recent study compared wild-type 
and 3-MST-deficient mice on hemodynamic or metabolic 
parameters and mortality in an experimental model of trau-
matic-hemorrhagic shock and observed no differences.40 
Taken together, the available evidence so far suggests that 
3-MST plays no major role in the pathogenesis of critical 
illness.
What, then, are the differences between 3-MST and CBS 
and CSE in terms of H2S production and related pathways 
that may explain these differences? First of all, 3-MST—in 
contrast to CBS and CSE—has a significant mitochondrial 
localization (although it is also present in the cytosol).41 Thus, 
the intracellular localization of the H2S it produces may be 
different, and therefore, the cellular pathways/targets affected 
by H2S may also be different. Second, 3-MST—in contrast to 
CBS and CSE—produces a significant amount of polysulfides 
(rather than, or in addition to “free” H2S).
41–43 Polysulfides 
Figure 8. Burn injury increases cytokine levels in plasma samples. Plasma cytokine levels, measured by Luminex analysis, are shown in wild-type 
(WT) mice and in 3-MST-/- mice subjected to sham injury or to burn injury (24 hours, 7 days, and 21 days). Burn markedly increased plasma KC 
(A), MCP-1 (B), RANTES (C), VEGF (D), G-CSF (E), and GM-CSF (F) levels in wild-type and 3-MST-/- mice at 24 hours, 7 days, and 21 days. 
Data are shown as mean ± SEM of 10 animals; *P < .05 shows signiﬁcant changes in response to burn, compared to the sham group.
Figure 9. Effect of burn injury on plasma troponin levels and burn wound area at Day 21. (A) Plasma troponin levels are shown in wild-type (WT) 
mice and in 3-MST-/- mice subjected to sham injury or to burn injury (24 hours, 7 days and 21 days). Burn markedly increased plasma troponin 
levels at 24 hours, 7 days, and 21 days; there was no statistically signiﬁcant difference between the values measured in the wild-type and the 3-MST-
/- burn group. *P < .05 shows signiﬁcant increases in response to burn, compared to the sham group. (B) % wound area on Day 21 is shown in 
the wild-type and 3-MST-/- burn group. Wound healing was comparable in the two groups of mice. Data are shown as mean ± SEM of 10 animals.
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have their own, very distinct regulatory roles in biological sys-
tems, which are fairly different from the roles of H2S, due 
to the different array of chemical reactions polysulfides can 
catalyze (most importantly, a post-translational modification 
of proteins via S-sulfhydration).44 As far as the net output of 
H2S from 3-MST vs CBS and CSE, no marked differences 
were noted (at least in the highly artificial conditions of tissue 
homogenates incubated with saturating concentrations of the 
respective substrates utilized in the current model). 3-MST is 
broadly expressed in all cells and tissues40,45 and therefore the 
lack of effect on MDA or MPO levels in the various organs 
studied here cannot be due to the absence of 3-MST in those 
organs. It is also not the case that 3-MST, in general, is not 
biologically relevant: multiple studies, in multiple models, 
have already implicated functional roles of this enzyme in vari-
ous biological systems ranging from neuronal roles to vascular 
and metabolic roles.41–53
Taken together, the data presented in the current paper do 
not find a major role of 3-MST in burn injury and support the 
concept that different H2S-producing enzymes (CBS, CSE, 
3-MST) can play substantially different roles in the pathogen-
esis of burn injury and other forms of critical illness.
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